CHIODO, TIZIANA,HAFNER, ANDREAS,HINTERMANN, TOBIAS,SALVADOR, BEATE,SZELAGIEWICZ, MARTIN,BLATTER, FRITZ,RODEL, EVA,VOSSEN, MARCUS
申请号：
CA2887540
公开号：
CA2887540A1
申请日:
2013.10.16
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
The present invention relates to crystalline materials comprising nilotinib and a carboxylic acid, carboxylic acid ester, carboxylic acid amide or sulfonic acid as a co-crystal former, and to pharmaceutical compositions comprising said materials. The invention also relates to processes for preparing said crystalline materials and to methods of using said crystalline materials to treat a disease condition in which tyrosine kinase inhibition is beneficial.
